JPMorgan Downgrades Enanta (ENTA) to Underweight, 'COVID Execution Standstill & Lengthy RSV Timelines Likely to Weigh Shares'
Tweet Send to a Friend
(Updated - August 9, 2023 6:22 AM EDT)
JPMorgan analyst Eric Joseph downgraded Enanta Pharmaceuticals (NASDAQ: ENTA) from to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Eric Joseph downgraded Enanta Pharmaceuticals (NASDAQ: ENTA) from to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
